Enveric Biosciences Correlations

ENVB Stock

USD 0.33 0.01 2.94%

The current 90-days correlation between Enveric Biosciences and Hepion Pharmaceuticals is -0.2 (i.e., Good diversification). The correlation of Enveric Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Enveric Biosciences Correlation With Market

Significant diversification

The correlation between Enveric Biosciences and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Enveric Biosciences and DJI in the same portfolio, assuming nothing else is changed.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enveric Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For information on how to trade Enveric Stock refer to our How to Trade Enveric Stock guide.

Moving together with Enveric Stock

0.75	VALN	Valneva SE ADR	Pair Corr
0.67	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.61	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.64	NKTX	Nkarta Inc	Pair Corr
0.69	BACK	IMAC Holdings	Pair Corr
0.62	TCHH	Trustcash Holdings	Pair Corr

Moving against Enveric Stock

0.52	RNXT	RenovoRx	Pair Corr
0.43	KZR	Kezar Life Sciences	Pair Corr
0.37	MDGL	Madrigal Pharmaceuticals	Pair Corr
0.71	CVX	Chevron Corp Fiscal Year End 7th of February 2025	Pair Corr
0.64	HD	Home Depot	Pair Corr
0.59	INTC	Intel Fiscal Year End 23rd of January 2025	Pair Corr
0.57	BAC	Bank of America Fiscal Year End 10th of January 2025	Pair Corr
0.56	AA	Alcoa Corp Fiscal Year End 15th of January 2025	Pair Corr
0.56	T	ATT Inc Aggressive Push	Pair Corr
0.5	CAT	Caterpillar Fiscal Year End 3rd of February 2025	Pair Corr
0.49	HPQ	HP Inc	Pair Corr
0.48	JPM	JPMorgan Chase Fiscal Year End 10th of January 2025	Pair Corr
0.38	GE	GE Aerospace Fiscal Year End 28th of January 2025	Pair Corr
0.36	IBM	International Business Fiscal Year End 22nd of January 2025	Pair Corr

Related Correlations Analysis

	OCEA	HEPA	ELEV	AVRO	CWBR	ZURA	EFTR
OCEA		0.42	0.34	-0.64	-0.46	0.3	0.43	OCEA
HEPA	0.42		0.74	-0.16	-0.48	-0.09	0.41	HEPA
ELEV	0.34	0.74		-0.06	-0.45	-0.03	0.6	ELEV
AVRO	-0.64	-0.16	-0.06		0.36	0.05	-0.26	AVRO
CWBR	-0.46	-0.48	-0.45	0.36		0.15	-0.28	CWBR
ZURA	0.3	-0.09	-0.03	0.05	0.15		-0.07	ZURA
EFTR	0.43	0.41	0.6	-0.26	-0.28	-0.07		EFTR
	OCEA	HEPA	ELEV	AVRO	CWBR	ZURA	EFTR

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ELEV	+ 0.74	HEPA
EFTR	+ 0.6	ELEV
EFTR	+ 0.43	OCEA
HEPA	+ 0.42	OCEA
EFTR	+ 0.41	HEPA
CWBR	+ 0.36	AVRO

High negative correlations

AVRO	- 0.64	OCEA
CWBR	- 0.48	HEPA
CWBR	- 0.46	OCEA
CWBR	- 0.45	ELEV
EFTR	- 0.28	CWBR
EFTR	- 0.26	AVRO

Risk-Adjusted Indicators

There is a big difference between Enveric Stock performing well and Enveric Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Enveric Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
OCEA	3.56	(0.56)	0.00	(1.39)	0.00	0.00	7.46	(6.93)	28.33
HEPA	3.82	(0.35)	0.00	(0.15)	0.00	0.00	8.06	(8.11)	33.54
ELEV	3.51	(0.59)	0.00	(0.17)	0.00	0.00	5.77	(8.22)	22.21
AVRO	1.77	0.18	0.01	(0.49)	1.89	(2.24)	4.11	(3.17)	14.20
CWBR	7.34	2.25	0.33	1.40	5.34	(11.19)	5.73	(5.59)	250.97
ZURA	3.89	(0.50)	0.00	(0.15)	0.00	0.00	7.95	(7.94)	30.69
EFTR	7.57	(4.50)	0.00	8.68	0.00	0.00	8.70	(27.78)	88.91

Enveric Biosciences Corporate Management

Joseph Tucker	CEO Director	Profile
Ibrahim MD	Chief Officer	Profile
MBA IV	Interim Officer	Profile
Peter Facchini	Chief Officer	Profile
Avani Kanubaddi	Pres COO	Profile
Kevin CPA	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC